Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 May 23;97(11):6055-60.
doi: 10.1073/pnas.100119497.

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

Affiliations

NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells

E D Cahir-McFarland et al. Proc Natl Acad Sci U S A. .

Abstract

Epstein-Barr virus (EBV) transforms B lymphocytes into lymphoblastoid cell lines usurping the Notch and tumor necrosis factor receptor pathways to effect transcription including NF-kappaB activation. To determine whether NF-kappaB activity is essential in the growth and survival of EBV-transformed lymphoblastoid cell lines, a nondegradable IkappaBalpha mutant was expressed under tetracycline regulation. Despite continued Bcl-2 and Bcl-x/L expression, NF-kappaB inhibition induced apoptosis as evidenced by poly(ADP-ribose) polymerase cleavage, nuclear condensation and fragmentation, and hypodiploid DNA content. Both caspase 3 and 8 activation and loss of mitochondrial membrane potential were observed in apoptotic cells. However, caspase inhibition failed to block apoptosis. These experiments indicate that NF-kappaB inhibitors may be useful in the therapy of EBV-induced cellular proliferation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Growth in Tc media induced Flag-ΔN-IκBα expression and inhibited NF-κB activity. (A) F-ΔN-IκBα expression was induced within 1 day after Tc withdrawal. Western blot analysis using M5 mAb. Lanes 1–3, extracts from cells grown in Tc+ media days 1–3; lanes 4–6, extracts from cells grown in Tc media, days 1–3. (B) EMSA indicated that F-ΔN-IκBα expression inhibited NF-κB activity. Two specific complexes were formed after incubating the extracts from A with a NF-κB probe from the HIV LTR marked κB-1 and κB-2. Lane 1, 100-fold mutant cold competitor. Lane 2, 100-fold excess wild-type cold competitor. Lanes 3–5, extracts from cells grown in Tc+ media, days 1–3; lanes 6–8, extracts from cells grown in Tc media, days 1–3
Figure 2
Figure 2
NF-κB inhibition down-regulated specific gene expression. (A) FACs analysis of ICAM-1 on cells grown in Tc+ (dashed line) or Tc- (solid line) media for 3 days. (B) Western blot analysis of extracts were examined for endogenous IκBα, TRAF1, and p53 expression. Lanes 1, 3, and 5 are extracts from cells grown in Tc+ media; lanes 2, 4, and 6 are from cells grown in Tc media. Lanes 1 and 2, day 1; lanes 3 and 4, day 2; and lanes 5 and 6, day 3. (C) c-Myc and LMP-1 expression was unaffected by inhibition of NF-κB. Lanes are as noted in B.
Figure 3
Figure 3
NF-κB inhibition caused apoptosis. (A) Cell growth was determined by counting on a hemacytometer with the inclusion of trypan blue. (Top) Total cell number—positive and negative for trypan blue. (Bottom) Cell number positive for trypan blue uptake. ⧫, Tc+ media; ■, Tc media. Cultures were initially seeded at 105/ml and counted at 24-h intervals thereafter. (B) Examination of DNA content on day 3 showed the accumulation of hypodiploid (<2 N) cells. After ethanol fixation, cells were stained with propidium iodide and examined by FACS. (Top) Tc+ media. (Bottom) Tc media. (C) Confocal microscopy showing apoptotic bodies of cells in B. (Left) Tc+. (Right) Tc.
Figure 4
Figure 4
PARP cleavage occurred before detectable activation of caspase-8 or Bid cleavage. Western blot analysis of extracts for pro-caspase 8, Bid, and PARP. Lanes 1, 3, and 5 are extracts from cells grown in Tc+ media. Lanes 2, 4, and 6 are from cells grown in Tc media. Lanes 1 and 2, day 1; lanes 3 and 4, day 2; and lanes 5 and 6, day 3.
Figure 5
Figure 5
Caspase activation was not required for F-ΔN-IκBα-mediated apoptosis. A total of 50 μM Z.VAD-FMK or 0.1% DMSO, the carrier, were added at day 0. Caspase 3 activity was determined by using the colorimetric substrate DEVD-pNA at Day 3. Cell viability was determined as in Fig. 3. PARP cleavage was determined as in Fig. 4. Lane 1, Tc+ media plus DMSO. Lane 2, Tc media plus DMSO. Lane 3, Tc media with 50 μM z-VAD.FMK.
Figure 6
Figure 6
NF-κB inhibition reduced A1/Bfl-1 expression, but not Bcl-x/L or Bcl-2 expression. (A) Western blot analysis of extracts for Bcl-x/L and Bcl-2. Lanes 1, 3, and 5 are extracts from cells grown in Tc+ media. lanes 2, 4, and 6 are from cells grown in Tc media. Lanes 1 and 2, day 1; lanes 3 and 4, day 2; and lanes 5 and 6, day 3. (B) Northern blot analysis. Five micrograms of total RNA generated on day 2 was analyzed for Bfl-1 (Left) and glyceraldehyde-3-phosphate dehydrogenase, (Right). Lane 1, Tc+ media. Lane 2, Tc media.
Figure 7
Figure 7
NF-κB inhibition caused a loss of mitochondrial potential but not Cyt c release. (A and B) DiOC6 fluorescence. (A) IB4 F-ΔN-IκBα cells grown in Tc+ media, gray line, in Tc media, black line. (B) BJAB, gray line, and BJAB treated with anti-Fas antibody, black line. (C) Cyt c release from the mitochondria. Western blots of S-100 pellets were analyzed for Cyt c. Lane 1, total cell extracts; lane 2, IB4 F-ΔN-IκBα cells, Tc+ media; lane 3, IB4 F-ΔN-IκBα cells, Tc media; lane 4, BJAB; lane 5, BJAB treated with anti-Fas.

References

    1. Rickinson A B, Kieff E. In: Fields Virology. Fields B N, Knipe D M, Howley P M, editors. Philadelphia: Lippincott–Raven; 1996. pp. 2397–2446.
    1. Kieff E. In: Fields Virology. Fields B N, Knipe D M, Howley P M, editors. Philadelphia: Lippincott–Raven; 1996. pp. 2343–2396.
    1. Grossman S R, Johannsen E, Tong X, Yalamanchili R, Kieff E. Proc Natl Acad Sci USA. 1994;91:7568–7572. - PMC - PubMed
    1. Izumi K M, Kieff E D. Proc Natl Acad Sci USA. 1997;94:12592–12597. - PMC - PubMed
    1. Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman S R. J Virol. 1995;69:253–262. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources